Loading…
XBiotech Inc. is projected to rise to $2.71 by 2027, a +22% move from its current price of $2.23. XBIT is currently trading below its 50-day average (a bearish sign). Technical indicators currently lean strong sell.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 8/3/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Aug 5 | $2.20 | $2.23 | $2.27 | +0.08% |
| Aug 6 | $2.19 | $2.23 | $2.28 | +0.16% |
| Aug 7 | $2.18 | $2.24 | $2.30 | +0.24% |
| Aug 8 | $2.17 | $2.24 | $2.31 | +0.32% |
| Aug 9 | $2.16 | $2.24 | $2.32 | +0.40% |
| Aug 10 | $2.16 | $2.24 | $2.33 | +0.48% |
| Aug 11 | $2.15 | $2.24 | $2.34 | +0.56% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $2.15 | $2.24 | $2.34 | +0.56% |
| Week 2 | $2.13 | $2.26 | $2.39 | +1.12% |
| Week 3 | $2.11 | $2.27 | $2.43 | +1.69% |
| Week 4 | $2.10 | $2.28 | $2.47 | +2.26% |
| Week 5 | $2.09 | $2.29 | $2.51 | +2.83% |
| Week 6 | $2.09 | $2.31 | $2.55 | +3.40% |
| Week 7 | $2.08 | $2.32 | $2.58 | +3.98% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
XBiotech Inc. is a healthcare company that discovers and develops True Human monoclonal antibodies for treating various diseases.
Its pipeline targets inflammatory and infectious diseases, and it is developing interleukin-1 alpha therapies to various medical conditions such as cancer, stroke, heart attack, or arthritis; and mediates tissue breakdown, angiogenesis, the formation of blood clots, malaise, muscle wasting, and general inflammation.
The company was incorporated in 2005 and is headquartered in Austin, Texas.
XBiotech Inc. (XBIT) is trading at $2.28 per share, with a market capitalization of $69.51M and a market rank of 4316.
Near-term the stock sits in a bearish technical setup, with RSI(14) at 40, and price action below the SMA50 ($2.36) and SMA200 ($2.42). These moving averages imply near-term resistance to a sustained move higher.
The thirty-day range runs from $2.06 to $2.53, with a defined support at $2.24 and a resistance at $2.41. Annualized volatility sits around 30%, signaling notable near-term risk alongside the current price dynamics. The forecast shows a long-term bullish trajectory, with the average price rising to $13.94 by 2050 and a maximum projected price of $22.79, yielding a 511.5% ROI in 2050.
A major floor 5.4% below — a decisive break under it would weaken the trend.
Price is testing support right now (0.0% away) — a key level to hold.
The nearest ceiling, 8.1% above — a clean break opens room to run.
A major ceiling 15.5% above — clearing it would confirm fresh momentum.
Key XBIT support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of XBIT market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $2.25 | Sell | $2.25 | Sell |
| MA 10 | $2.26 | Sell | $2.26 | Sell |
| MA 20 | $2.29 | Sell | $2.28 | Sell |
| MA 50 | $2.33 | Sell | $2.32 | Sell |
| MA 100 | $2.38 | Sell | $2.37 | Sell |
| MA 200 | $2.41 | Sell | $2.53 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 36.62 | Neutral |
| Stoch RSI (14) | 13.43 | Buy |
| CCI (20) | -114.40 | Sell |
| Williams %R (14) | -100.00 | Info |
| MACD (12,26,9) | -0.00 | Sell |
| ROC (12) | -2.62 | Sell |
| Bollinger %B (20,2) | 0.19 | Neutral |
| Stochastic %K (14) | 0.00 | Buy |
| TRIX (15) | -0.16 | Sell |
| Awesome (5,34) | -0.05 | Sell |
| Ultimate (7,14,28) | 27.51 | Buy |
| Momentum (10) | -0.04 | Sell |
| Aroon Osc (25) | -76.00 | Sell |
| Hull MA (9) | 2.24 | Sell |
| ADX (14) | 18.75 | Neutral |
| ATR (14) | 0.02 | Info |
The 30-day picture shows bearish sentiment for now, with RSI at 40 and prices trading below the near-term moving averages.
Current price of $2.28 sits just above the $2.24 support and below the $2.41 resistance, within the $2.06–$2.53 30-day range. This setup suggests limited near-term upside unless a breakout above $2.41 occurs, given the present volatility of about 30%.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $2.23 | $2.23 | $3.11 | 0% | Neutral | |
| $2.22 | $2.71 | $3.45 | +22% | Bullish | |
| $2.28 | $2.83 | $3.70 | +27% | Bullish | |
| $2.48 | $3.13 | $4.19 | +40% | Bullish | |
| $2.41 | $3.08 | $4.20 | +38% | Bullish | |
| $2.51 | $3.25 | $4.49 | +46% | Bullish | |
| $2.78 | $3.64 | $5.11 | +63% | Bullish | |
| $3.10 | $4.10 | $5.82 | +84% | Bullish | |
| $3.53 | $4.72 | $6.79 | +112% | Bullish | |
| $3.59 | $4.84 | $7.04 | +117% | Bullish | |
| $4.75 | $6.68 | $10.19 | +200% | Bullish | |
| $8.11 | $12.24 | $20.01 | +449% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| August 2026 | $2.23 | $2.23 | $2.77 | +0.00% |
| September 2026 | $2.04 | $2.39 | $2.86 | +7.17% |
| October 2026 | $2.04 | $2.40 | $2.90 | +0.34% |
| November 2026 | $2.09 | $2.47 | $3.00 | +2.90% |
| December 2026 | $2.15 | $2.55 | $3.11 | +3.32% |
Click any year to see its month-by-month XBIT forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
In 2026, XBIT is projected to trade between $2.23 and $3.11, averaging $2.23 — a potential gain of 0% from today's $2.23. Price action looks broadly range-bound.
XBiotech Inc.'s 2027 outlook centres on $2.71, within a $2.22 to $3.45 range. That is up +22% on the projected 2026 average. That marks a +22% change versus current levels. Buyers look set to stay in control over this stretch.
By 2028, XBIT could reach as high as $3.70, with a base case around $2.83 and support toward $2.28 — roughly +27% from $2.23. Momentum favours further upside here.
Expect XBIT to range from $2.48 to $4.19 through 2029. The $3.13 average target implies a +40% move from current prices. That is up +11% on the projected 2028 average. Buyers look set to stay in control over this stretch.
The XBIT price prediction for 2030 points to an average of $3.08 (low $2.41, high $4.20) — a potential gain of +38% on today's $2.23. Momentum favours further upside here.
In 2031, XBIT is projected to trade between $2.51 and $4.49, averaging $3.25 — a potential gain of +46% from today's $2.23. That is up +5% on the projected 2030 average. Buyers look set to stay in control over this stretch.
XBiotech Inc.'s 2032 outlook centres on $3.64, within a $2.78 to $5.11 range. That is up +12% on the projected 2031 average. That marks a +63% change versus current levels. Momentum favours further upside here.
By 2033, XBIT could reach as high as $5.82, with a base case around $4.10 and support toward $3.10 — roughly +84% from $2.23. Buyers look set to stay in control over this stretch.
Expect XBIT to range from $3.53 to $6.79 through 2034. The $4.72 average target implies a +112% move from current prices. That is up +15% on the projected 2033 average. Momentum favours further upside here.
The XBIT price prediction for 2035 points to an average of $4.84 (low $3.59, high $7.04) — a potential gain of +117% on today's $2.23. Buyers look set to stay in control over this stretch.
In 2040, XBIT is projected to trade between $4.75 and $10.19, averaging $6.68 — a potential gain of +200% from today's $2.23. That is up +38% on the projected 2035 average. Momentum favours further upside here.
XBiotech Inc.'s 2050 outlook centres on $12.24, within a $8.11 to $20.01 range. That is up +83% on the projected 2040 average. That marks a +449% change versus current levels. Buyers look set to stay in control over this stretch.
Investing $1,000 in XBIT today (≈ 448.430493 XBIT) could be worth
$5,489.79
+$4,489.79 (+449%) by 2050 · US Dollar
Based on the average projected XBIT price of $12.24 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in XBITwould be worth at today's price.
$1,000 invested in XBIT on Jul 31, 2025 (≈ 344.827575 XBIT) would be worth
$768.97
-$231.03 (-23.1%) today · 0.77× · US Dollar
Based on a XBIT entry price of $2.9 vs. today's $2.23.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $2.27 | $982.38 | -1.8% |
| 1 month ago | $2.3 | $969.57 | -3.0% |
| 3 months ago | $2.55 | $874.51 | -12.5% |
| 6 months ago | $2.48 | $899.19 | -10.1% |
| 1 year ago | $2.9 | $768.97 | -23.1% |
| All time (5.0y) ago | $15.98 | $139.55 | -86.0% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our XBIT forecast.
Our base-case forecast reaches $4.50 around 2034.
Implied market cap at $4.50: $137.19M
The multi-year forecast maps a bullish path from 2027 onward, with 2027 avg $2.79 and ROI 22.4% (sentiment BULLISH), 2028 avg $2.97 and ROI 30.4%, and 2029 avg $3.31 with ROI 45.2%. By 2030 the avg is $3.26 with ROI 43.2% and bullish sentiment.
The trajectory continues higher, with 2031 avg $3.51 (ROI 54.1%), 2032 avg $3.99 (ROI 75%), 2033 avg $4.50 (ROI 97.4%), 2034 avg $5.22 (ROI 129.1%), and 2035 avg $5.32 (ROI 133.4%), all marked as BULLISH.
Looking further out, the forecast shows 2040 avg $7.68 (ROI 236.7%) and 2050 avg $13.94 (ROI 511.5%), both with bullish sentiment. These figures indicate substantial long-term upside, tempered by near-term bearish signals and the inherent uncertainty in any price forecast.
Tap a question to reveal the answer.
2030 — min $2.55, avg $3.26, max $4.45; ROI 43.2%; sentiment BULLISH.
The forecast shows a bullish trend from 2027 onward, with rising averages and ROI culminating at 511.5% by 2050 (2040 max $11.71, 2050 max $22.79). Earlier years like 2026 show neutral sentiment and a 0% ROI.
Yes. The forecast lists a 2040 max of $11.71 and a 2050 max of $22.79, indicating a path that exceeds $10 by those years.
BEARISH.
$2.06 to $2.53.
XBiotech Inc. Community Discussion
0Share your XBiotech Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.